Gilead Sciences Switzerland Sàrl
- J01 - Antibacterianos para uso sistémico
- CAYSTON powder for nebuliser solution 75 mg
- J02 - Antimicóticos de uso sistémico
- AMBISOME powder for solution for infusion 50 mg
- J05 - Antivirales de uso sistémico
- BIKTARVY film-coated tablet 50 mg+200 mg+25 mg
- DESCOVY film-coated tablet 200 mg+10 mg
- DESCOVY film-coated tablet 200 mg+25 mg
- EMTRIVA capsule, hard 200 mg
- EPCLUSA film-coated tablet 400 mg+100 mg
- EVIPLERA film-coated tablet 200 mg+245 mg+25 mg
- GENVOYA film-coated tablet 150 mg+150 mg+200 mg+10 mg
- HARVONI film-coated tablet 400 mg+90 mg
- ODEFSEY film-coated tablet 200 mg+25 mg+25 mg
- SOVALDI film-coated tablet 400 mg
- STRIBILD film-coated tablet 200 mg+245 mg+150 mg+150 mg
- SUNLENCA film-coated tablet 300 mg
- SUNLENCA solution for injection 463.5 mg/1.5 ml
- TRUVADA film-coated tablet 245 mg+200 mg
- VEKLURY powder for solution for infusion 100 mg
- VEMLIDY film-coated tablet 25 mg
- VIREAD film-coated tablet 245 mg
- VOSEVI film-coated tablet 400 mg+100 mg+100 mg
- L01 - Antineoplásicos
- TECARTUS dispersion 40 to 200 M.cells
- TRODELVY powder for solution for infusion 200 mg
- YESCARTA dispersion
- ZYDELIG film-coated tablet 100 mg
- ZYDELIG film-coated tablet 150 mg
- V03 - Todos los demás preparados terapéuticos
- TYBOST film-coated tablet 150 mg